000168184 001__ 168184
000168184 005__ 20260128122452.0
000168184 0248_ $$2sideral$$a64590
000168184 037__ $$aART-2009-64590
000168184 041__ $$aeng
000168184 100__ $$0(orcid)0000-0003-2928-6623$$aGimeno Feliu, L. A.$$uUniversidad de Zaragoza
000168184 245__ $$aComparative Study of Paediatric Prescription Drug Utilization between the Spanish and Immigrant Population
000168184 260__ $$c2009
000168184 5060_ $$aAccess copy available to the general public$$fUnrestricted
000168184 5203_ $$aBackground: The immigrant population has increased greatly in Spain in recent years to the point where immigrants made up 12% of the infant population in 2008. There is little information available
on the profile of this group with regard to prescription drug utilization in universal public health care systems such as that operating in Spain. This work studies the overall and specific differences
in prescription drug utilization between the immigrant and Spanish population.
Methods: Use was made of the Aragonese Health Service databases for 2006. The studied population comprises 159,908 children aged 0-14 years, 13.6% of whom are foreign nationals. Different utilization variables were calculated for each group. Prescription-drug consumption is measured in Defined Daily Doses (DDD) and DDD/1000 persons/day/(DID).
Results: A total of 833,223 prescriptions were studied. Utilization is lower for immigrant children
than in Spanish children for both DID (66.27 v. 113.67) and average annual expense (€21.55 v. €41.14). Immigrant children consume fewer prescription drugs than Spanish children in all of the
therapy groups, with the most prescribed (in DID) being: respiratory system, anti-infectives for systemic use, nervous system, sensory organs. Significant differences were observed in relation to
the type of drugs and the geographical background of immigrants.
Conclusion: Prescription drug utilization is much greater in Spanish children than in immigrant children, particularly with reference to bronchodilators (montelukast and terbutaline) and attention-disorder hyperactivity drugs such as methylphenidate. There are important differences regarding drug type and depending on immigrants' geographical backgrounds that suggest there are social, cultural and access factors underlying these disparities.
000168184 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000168184 590__ $$a2.328$$b2009
000168184 591__ $$aTROPICAL MEDICINE$$b5 / 17 = 0.294$$c2009$$dQ2$$eT1
000168184 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b40 / 121 = 0.331$$c2009$$dQ2$$eT2
000168184 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000168184 700__ $$aArmesto,F. J.
000168184 700__ $$aMacipe Costa,R. M.
000168184 700__ $$aEsteban,E. A.
000168184 700__ $$0(orcid)0000-0002-5494-6550$$aMagallón Botaya,R.$$uUniversidad de Zaragoza
000168184 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000168184 773__ $$g14 (2009), 71-71$$pTM IH, Trop. med. int. health$$tTROPICAL MEDICINE & INTERNATIONAL HEALTH$$x1360-2276
000168184 8564_ $$s591830$$uhttps://zaguan.unizar.es/record/168184/files/texto_completo.pdf$$yVersión publicada
000168184 8564_ $$s1966720$$uhttps://zaguan.unizar.es/record/168184/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000168184 909CO $$ooai:zaguan.unizar.es:168184$$particulos$$pdriver
000168184 951__ $$a2026-01-28-11:23:00
000168184 980__ $$aARTICLE